glp-1 afib New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib — independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight Effects of Glucagon-Like Peptide-1 Receptor

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

Wegovy was the companys first oral biologic, and the current collaboration builds on launch of the pill form of semaglutide, granted US approval earlier this year as the worlds first oral biologic for obesity

The paper explores the science at the intersection of metabolic hormones and precision nutrition and multi-target therapies, like tirzepatide and retatrutide.

The ERME (Enzyme Rich Malt Extract) in JUVIA contains over 15 different enzymes specifically designed to break down complex carbohydratesthe very compounds that serve as fuel for GLP-1-producing bacteria

Early fullness and prolonged fullness are common warning signs of delayed stomach emptying